Multiple sclerosis (MS) involves the progressive loss of the protective layer of nerve fibers, myelin, and its loss, called demyelination, results in symptoms of MS. Blocking the protein receptor, ...

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...

Two papers by UB researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to treat it. The findings include the ...

Please provide your email address to receive an email when new articles are posted on . Nearly all patients in the open-label extension of VISIONARY-MS showed MRI evidence of neuronal repair and ...

The therapeutic landscape for multiple sclerosis (MS) is evolving beyond modulating the peripheral immune response. New strategies are now focussed on reducing inflammation and promoting the ...

Global Neurology Leaders to Support Development of a Potentially Restorative Treatment for MS as Program Advances Toward 2023 Regulatory Filing Company also Expands Regenerative Medicine Advisory ...

Ari Green, MD, of the University of California, San Francisco, details the benefits of remyelination for patients with multiple sclerosis (MS), as well as the challenges faced when conducting ...

As described in the journal Cell Reports, the team found that in adult stem cells, the activation of a specific transcription factor induces pathological quiescence – where the stem cells become ...

Two papers by UB researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to treat it. The findings include the ...

PARIS — A monoclonal antibody directed against a human retroviral protein thought to play a role in the multiple sclerosis (MS) disease process did not show a significant effect on the primary ...